Welldoc and Lilly collaborate to integrate BlueStar® app capabilities into Lilly’s connected insulin solutions

COLUMBIA, Md. and INDIANAPOLIS, Feb. 25, 2021 /PRNewswire/ — Welldoc, Inc., and Eli Lilly and Company (NYSE: LLY) announced today a collaboration and licensing agreement to integrate Welldoc’s software into Lilly’s connected insulin solutions, currently in development. Under the terms of…

About the Author

has written 20652 stories on this site.

Copyright © 2010-2019 strategicbusinessnews.com